OBJECTIVES: To examine the influence of knowledge of HIV serostatus on changes in risk behaviors among injecting drug users (IDU). PROCEDURES: IDU were recruited through sampling conducted at street drug-selling areas. Of 374 participants, 88.8% consented to be HIV tested and returned for their test results, and 73.5% were relocated and interviewed 6 months later. RESULTS: Of the 176 IDU who reported a seronegative test result prior to baseline, 29 tested seropositive at baseline. No significant differences were found between HIV-positive and HIV-negative IDU in needle risk behaviors. HIV-positive IDU were significantly less likely to report being sexually active [odds ratio (OR), 0.41 : 95% confidence interval (CI), 0.22-0.75] and more likely to use condoms during vaginal (OR, 4.43; 95% CI, 1.48-13.29) and oral sex (OR, 6.67; 95% CI, 1.42-31.33). CONCLUSION: The findings of this study show the importance of encouraging IDU to undergo periodic retesting. HIV testing could have an important role in reducing heterosexual transmission from IDU.
OBJECTIVES: To examine the influence of knowledge of HIV serostatus on changes in risk behaviors among injecting drug users (IDU). PROCEDURES: IDU were recruited through sampling conducted at street drug-selling areas. Of 374 participants, 88.8% consented to be HIV tested and returned for their test results, and 73.5% were relocated and interviewed 6 months later. RESULTS: Of the 176 IDU who reported a seronegative test result prior to baseline, 29 tested seropositive at baseline. No significant differences were found between HIV-positive and HIV-negative IDU in needle risk behaviors. HIV-positive IDU were significantly less likely to report being sexually active [odds ratio (OR), 0.41 : 95% confidence interval (CI), 0.22-0.75] and more likely to use condoms during vaginal (OR, 4.43; 95% CI, 1.48-13.29) and oral sex (OR, 6.67; 95% CI, 1.42-31.33). CONCLUSION: The findings of this study show the importance of encouraging IDU to undergo periodic retesting. HIV testing could have an important role in reducing heterosexual transmission from IDU.
Authors: Blair T Johnson; Lori A J Scott-Sheldon; Natalie D Smoak; Jessica M Lacroix; John R Anderson; Michael P Carey Journal: J Acquir Immune Defic Syndr Date: 2009-08-01 Impact factor: 3.731
Authors: Yan Yao; Ning Wang; Jennifer Chu; Guowei Ding; Xia Jin; Yongli Sun; Guixiang Wang; Junjie Xu; Kumi Smith Journal: Int J Infect Dis Date: 2008-09-07 Impact factor: 3.623